Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 22, 2012

Regular aspirin intake halves risk of hereditary cancer

Bookmark and Share

Scientists including those from Queen’s University have discovered that the number of people developing hereditary cancer could be halved by taking regular aspirin. Colorectal cancer is one of the most common forms of hereditary cancers, with 10 per cent of these cancer cases being thought to be hereditary. Some researchers had noticed that patients prescribed [...]

Benefit-risk balance of angiotensin II receptor antagonists remains positive

Bookmark and Share

Review of evidence does not suggest any link between angiotensin II receptor antagonists and  cancer The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has reviewed the possible link between the use of angiotensin II receptor antagonists (ARBs) and the development of new cancers. They concluded that the evidence does not support [...]

International Research including UCC identified BP Genes

Bookmark and Share

Scientists from a large international academic consortium including University College Cork (UCC), have identified genetic variants associated with blood pressure in individuals of European descent. Their research provides new insights into genetics that could contribute to the treatment of high blood pressure. The findings were published last month in the prestigious journal Nature Genetics. Genetic [...]

Irish University Pioneers Prostate Cancer Breakthrough

Bookmark and Share

Scientists at Queen’s University Belfast have pioneered a new combination treatment for prostate cancer. The treatment is aimed at men with an advanced and aggressive form of prostate cancer which has spread to the bone. The first of its kind to be developed, it combines traditional chemotherapy with two doses of a radioactive chemical that [...]